1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 8th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Medicina: Special Issue "ME/CFS: Causes, Clinical Features and Diagnosis" Deadline Dec 2020

Discussion in 'General ME/CFS news' started by John Mac, Apr 27, 2020.

  1. John Mac

    John Mac Senior Member (Voting Rights)

    Messages:
    921
    https://www.mdpi.com/journal/medici...ic_encephalomyelitis_chronic_fatigue_syndrome
     
  2. Sly Saint

    Sly Saint Senior Member (Voting Rights)

    Messages:
    9,582
    Location:
    UK
    Simon M, DokaGirl and Andy like this.
  3. Mithriel

    Mithriel Senior Member (Voting Rights)

    Messages:
    2,816
    Derek Pheby was the guy who wanted a large study done to see exactly what people with ME felt their symptoms were, but they gave the money to the PACE trial instead. It was all part of the debacle after the CMOs report. A time that seemed hopeful but turned out not to be.
     
  4. Andy

    Andy Committee Member

    Messages:
    21,914
    Location:
    Hampshire, UK
    I've seen the ME Association say that they have paid that kind of amount in order for a paper to be open-access (can't remember which one though).
     
    alktipping and DokaGirl like this.
  5. Dolphin

    Dolphin Senior Member (Voting Rights)

    Messages:
    5,084
    They paid for this paper to be open access:

    Can patients with chronic fatigue syndrome really recover after graded exercise or cognitive behavioural therapy? A critical commentary and preliminary re-analysis of the PACE trial
    https://www.tandfonline.com/doi/full/10.1080/21641846.2017.1259724

    Also
    Rethinking the treatment of chronic fatigue syndrome—a reanalysis and evaluation of findings from a recent major trial of graded exercise and CBT
    https://bmcpsychology.biomedcentral.com/articles/10.1186/s40359-018-0218-3
     

Share This Page